Headline News

Patients with glaucoma treated with iDose TR experienced sustained IOP reductions, according to a press release from Glaukos.

The prevalence of intraventricular hemorrhage among preterm infants has not changed over time, but it occurs later in life than it did 20 to 30 years ago, according to the results of a large study published in JAMA Pediatrics.

The risk for acne relapse following isotretinoin use is reduced with higher cumulative doses, suggesting individualized treatment plans based on patients’ goals could maximize efficacy, according to researchers.

Alcohol consumption may trigger worse allergic reactions in patients with nut allergies, according to a study published in International Archives of Allergy and Immunology.

Patients with HIV and hepatitis B coinfection are at an increased risk for hepatitis D, which is associated with an increased risk of liver-related complications and mortality, researchers found.

The FDA has advised health care professionals that they should not use unapproved epinephrine nasal solutions manufactured by BPI Labs LLC and Endo USA.

The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs. cigarettes and other tobacco products.

The FDA approved two oncology regimens on Jan. 16.

Bausch + Lomb acquired Whitecap Biosciences, including its two therapies for potential use in glaucoma and geographic atrophy, to strengthen its clinical-stage pipeline, according to a press release.